Bio-Pharma innovation

Vancouver, Canada, Oct. 28, 2025 — Augurex Life Sciences announced FDA Breakthrough Device Designation for its SPINEstat® blood test,...

Dallas, TX – October 24, 2025: OncoNano Medicine, a clinical-stage biotechnology company, announced it will present new data at...

Foster City, California – October 20, 2025 — Gilead Sciences, Inc. (Nasdaq: GILD) announced that it will present new...

Barcelona, Spain – October 15, 2025 – Gilead Sciences, Inc. (NASDAQ: GILD) unveiled new data across its HIV prevention...

MONMOUTH, N.J., Sept. 18, 2025 A new investigational therapy, JD-004, has received Orphan Drug Designation (ODD) from the U.S. Food...

September 9, 2025 – Raritan, N.J. – In a landmark regulatory milestone, Johnson & Johnson (NYSE: JNJ) announced U.S....